Earnings Per Share

3 Months Ended

Mar. 31, 2025

Basic and diluted earnings (loss) per share is calculated based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings (loss) per share. A reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share follows (dollars in millions, except per share amounts; shares in thousands):


	Three Months Ended March 31,
		2025		2024

Numerator:
Net loss attributable to Surgery Partners, Inc.		$	(37.7)	$	(12.4)



Denominator:
Weighted average common shares outstanding:
Basic		126,602		125,972
Diluted (1)		126,602		125,972

Net loss per share attributable to common stockholders:
Basic		$	(0.30)	$	(0.10)
Diluted (1)		$	(0.30)	$	(0.10)

Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive:
Stock options		957		1,237
Restricted shares		138		148

(1)The impact of potentially dilutive securities for all periods was not considered because the effect would be anti-dilutive.